rs376317481
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The ENST00000367721.3(FASLG):āc.749A>Gā(p.Asn250Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000608 in 1,612,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N250I) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000367721.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FASLG | NM_000639.3 | c.749A>G | p.Asn250Ser | missense_variant | 4/4 | ENST00000367721.3 | NP_000630.1 | |
FASLG | NM_001302746.2 | c.*319A>G | 3_prime_UTR_variant | 3/3 | NP_001289675.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FASLG | ENST00000367721.3 | c.749A>G | p.Asn250Ser | missense_variant | 4/4 | 1 | NM_000639.3 | ENSP00000356694 | P1 | |
FASLG | ENST00000340030.4 | c.*319A>G | 3_prime_UTR_variant | 3/3 | 1 | ENSP00000344739 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250988Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135618
GnomAD4 exome AF: 0.0000466 AC: 68AN: 1460414Hom.: 0 Cov.: 33 AF XY: 0.0000578 AC XY: 42AN XY: 726220
GnomAD4 genome AF: 0.000197 AC: 30AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74326
ClinVar
Submissions by phenotype
Autoimmune lymphoproliferative syndrome type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 26, 2021 | This sequence change replaces asparagine with serine at codon 250 of the FASLG protein (p.Asn250Ser). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and serine. This variant is present in population databases (rs376317481, ExAC 0.002%). This variant has not been reported in the literature in individuals affected with FASLG-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at